Salivary and serum interleukin 6 and basic fibroblast growth factor levels in patients with oral squamous cell carcinoma

Minerva Stomatol. 2005 Oct;54(10):569-73.

Abstract

Aim: A role of various cytokines has been implicated in the pathogenesis of many carcinomas, and albeit the role of interleukin 6 (IL-6) and basic fibroblast growth factor (bFGF) in sera has been studied in patients with oral carcinomas, data upon salivary IL-6 and bFGF are lacking. The aim of this study was to evaluate levels of IL-6 and bFGF in the saliva and serum of patients with oral squamous cell carcinoma.

Methods: Salivary and serum IL-6 and bFGF were evaluated in a group of 33 patients (28 men, 5 women) with oral squamous cell carcinoma (OSCC), age range 40-73 years , mean 54.05 years. Control group consisted of 23 healhy participants, mean age 25 years.

Results: Serum IL-6 and bFGF levels were not significantly different between patients with OSCC and healthy controls. Elevated levels of salivary IL-6 and bFGF in patients with OSCC when compared to the healthy controls were found (p<0.001).

Conclusions: The conclusion is drawn that higher levels of salivary IL-6 and bFGF in patients with OSCC might originate from the local production, probably from carcinoma cells.

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Squamous Cell / immunology*
  • Female
  • Fibroblast Growth Factor 2 / analysis*
  • Fibroblast Growth Factor 2 / blood
  • Humans
  • Interleukin-6 / analysis*
  • Interleukin-6 / blood
  • Male
  • Middle Aged
  • Mouth Neoplasms / immunology*
  • Saliva / chemistry*

Substances

  • Interleukin-6
  • Fibroblast Growth Factor 2